GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Trxade Health Inc (FRA:4E40) » Definitions » Cyclically Adjusted FCF per Share

Trxade Health (FRA:4E40) Cyclically Adjusted FCF per Share : €0.00 (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Trxade Health Cyclically Adjusted FCF per Share?

Note: As Cyclically Adjusted FCF per Share is a main component used to calculate Cyclically Adjusted Price-to-FCF. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation section below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Trxade Health's adjusted free cash flow per share for the three months ended in Dec. 2023 was €-0.972. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €0.00 for the trailing ten years ended in Dec. 2023.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 90.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Trxade Health was 90.70% per year. The lowest was 90.20% per year. And the median was 90.45% per year.

As of today (2024-06-01), Trxade Health's current stock price is €6.862. Trxade Health's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 was €0.00. Trxade Health's Cyclically Adjusted Price-to-FCF of today is .


Trxade Health Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Trxade Health's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trxade Health Cyclically Adjusted FCF per Share Chart

Trxade Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -3,085.04 -3,628.78 - -

Trxade Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -1.82 -3.33 -

Competitive Comparison of Trxade Health's Cyclically Adjusted FCF per Share

For the Pharmaceutical Retailers subindustry, Trxade Health's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Trxade Health's Cyclically Adjusted Price-to-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Trxade Health's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Trxade Health's Cyclically Adjusted Price-to-FCF falls into.



Trxade Health Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Trxade Health's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.972/129.4194*129.4194
=-0.972

Current CPI (Dec. 2023) = 129.4194.

Trxade Health Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 -0.556 99.695 -0.722
201406 -0.367 100.560 -0.472
201409 -0.678 100.428 -0.874
201412 -0.855 99.070 -1.117
201503 -0.986 99.621 -1.281
201506 -0.836 100.684 -1.075
201509 -0.231 100.392 -0.298
201512 -3.117 99.792 -4.042
201603 -0.212 100.470 -0.273
201606 -0.697 101.688 -0.887
201609 -0.880 101.861 -1.118
201612 -1.642 101.863 -2.086
201703 -0.118 102.862 -0.148
201706 0.127 103.349 0.159
201709 0.259 104.136 0.322
201712 0.119 104.011 0.148
201803 0.143 105.290 0.176
201806 0.178 106.317 0.217
201809 0.189 106.507 0.230
201812 0.093 105.998 0.114
201903 -0.280 107.251 -0.338
201906 0.101 108.070 0.121
201909 0.911 108.329 1.088
201912 -0.379 108.420 -0.452
202003 -0.796 108.902 -0.946
202006 -6.281 108.767 -7.474
202009 3.918 109.815 4.617
202012 -1.091 109.897 -1.285
202103 -1.104 111.754 -1.279
202106 -1.061 114.631 -1.198
202109 -1.153 115.734 -1.289
202112 -0.695 117.630 -0.765
202203 -1.668 121.301 -1.780
202206 -2.044 125.017 -2.116
202209 -1.056 125.227 -1.091
202212 1.816 125.222 1.877
202303 -1.417 127.348 -1.440
202306 0.376 128.729 0.378
202309 -0.239 129.860 -0.238
202312 -0.972 129.419 -0.972

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Trxade Health  (FRA:4E40) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Trxade Health Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Trxade Health's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Trxade Health (FRA:4E40) Business Description

Traded in Other Exchanges
Address
2420 Brunello Trace., Lutz, FL, USA, 33558
Trxade Health Inc is a health service IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey, and patient engagement in the U.S. Its product and services include Integra Pharma Solutions, LLC, Community Specialty Pharmacy, LLC, Delivmeds.com, Bonum Health Hub and Application, and others. its business is classified into reportable segments which are Trxade, Inc, Community Specialty Pharmacy, LLC, Integra Pharma, LLC, and Other, and the majority of the revenue comes from Trxade, Inc.

Trxade Health (FRA:4E40) Headlines

No Headlines